Sit Investment Associates’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1K Hold
177
﹤0.01% 497
2025
Q4
$1K Hold
177
﹤0.01% 510
2025
Q3
$2K Hold
177
﹤0.01% 513
2025
Q2
$3K Sell
177
-1
-0.6% -$16 ﹤0.01% 520
2025
Q1
$2K Hold
178
﹤0.01% 521
2024
Q4
$3K Hold
178
﹤0.01% 529
2024
Q3
$2K Hold
178
﹤0.01% 538
2024
Q2
$10K Hold
178
﹤0.01% 528
2024
Q1
$6K Hold
178
﹤0.01% 520
2023
Q4
$14K Hold
178
﹤0.01% 527
2023
Q3
$29K Hold
178
﹤0.01% 515
2023
Q2
$58K Hold
178
﹤0.01% 516
2023
Q1
$49K Hold
178
﹤0.01% 509
2022
Q4
$69K Hold
178
﹤0.01% 506
2022
Q3
$43K Hold
178
﹤0.01% 502
2022
Q2
$40K Hold
178
﹤0.01% 499
2022
Q1
$121K Hold
178
﹤0.01% 483
2021
Q4
$123K Buy
+178
New +$132K ﹤0.01% 484
2021
Q3
Sell
-178
Closed -$133K 514
2021
Q2
$133K Buy
+178
New +$136K ﹤0.01% 490

Other funds holding OM

Sit Investment Associates's OM Position: Q1 2026 in Review

Sit Investment Associates held its Outset Medical (OM) position steady in Q1 2026 at 177 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #497.

Sit Investment Associates first reported a position in OM in Q2 2021 and has held it in 19 quarters since. The position peaked at $133K in Q2 2021. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • Sit Investment Associates held 177 shares of Outset Medical worth $1K as of Q1 2026.
  • Sit Investment Associates left its Outset Medical share count unchanged in Q1 2026.
  • Outset Medical made up ﹤0.01% of Sit Investment Associates's portfolio in Q1 2026, its #497 holding.
  • Sit Investment Associates first reported a position in Outset Medical in Q2 2021 and has held it in 19 quarters since.
  • Sit Investment Associates's Outset Medical position peaked at $133K in Q2 2021.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Sit Investment Associates's 13F filing for Q1 2026, filed 13 May 2026.